Excellent Packaging Engineering - Bosch Machine Honoured with Red Dot Award
For the first time, Bosch Packaging Technology has received the internationally renowned “Red Dot Award” from the Design Zentrum Nordrhein-Westfalen in the category product design. The independent 38-member jury announced on 30 March that it awards the company with an “Honourable Mention” and acknowledges the well-executed design achievement of the FXS Combi. The filling and closing machine for pre-sterilized nested syringes, vials and cartridges (small glass containers), developed at the site in Crailsheim, is the first machine from the Packaging Technology division to receive this important design award.
“We are very happy about the Red Dot Award, which underlines our expertise in the development of innovative solutions for the pharmaceutical industry. The award shows that our products are not only convincing in terms of quality. They also stand out internationally because of their design,” says Klaus Ullherr, product manager at Bosch in Crailsheim. The international experts assessed a total of 4 928 entries from 56 countries. On June 29, the internationally renowned product competition will culminate in the Red Dot gala.
Flexibility for Various Packaging Types
The FXS Combi, which was launched at Interpack 2014, offers particular flexibility and safety. The machine is suited for three different pre-sterilized packaging types, as well as all common filling technologies. As the first filling and closing machine of this kind, the FXS Combi features an integrated capping station for vials and cartridges. Here, the containers are immediately closed after filling to ensure the highest pharmaceutical safety. By combining the machine with proven tub and bag openers, as well as different barrier systems, the FXS Combi can be flexibly integrated into complete line concepts, while allowing for significant space savings. Visitors to Achema 2015 can see for themselves in Frankfurt/Main, Germany, 15–19 June (hall 3.1, booth C71).
The Red Dot Award
The Red Dot Award was created by the Design Zentrum Nordrhein-Westfalen and is one of the best-respected design competitions in the world with approximately 17 000 entries each year. In 2015, the award is celebrating its 60th anniversary. In 1955, a jury convened for the first time to assess the best designs of the time. Today it consists of 38 members. The sought-after award, the “Red Dot”, is the internationally respected seal for outstanding design quality.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.